Prescription drug · ANDA
Acyclovir suspension (Acyclovir) NDC 17856-2170
Acyclovir 200 mg/5mL · Suspension · Oral · Atlantic Biologicals Corp.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17856-2170-1 | 1785621700117856217001 | 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSEMarketed from May 4, 2026 | |
| 17856-2170-2 | 1785621700217856217002 | 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSEMarketed from May 4, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Acyclovir suspension
- Generic name (nonproprietary)
- acyclovir
- Active ingredients
- Acyclovir — 200 mg/5mL
- Dosage form
- Suspension
- Route
- Oral
- Labeler
- Atlantic Biologicals Corp.NDC labeler code 17856
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217393
- Marketing start
- Listing expires
- Other FDA classes
- DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
- Identifiers
- Product ID 17856-2170_5105272f-cff9-8898-e063-6394a90aabb5SPL ID 5105272f-cff9-8898-e063-6394a90aabb5SPL set ID 5105272f-cff8-8898-e063-6394a90aabb5RxCUI 307730UNII X4HES1O11F
- Pharmacologic class
- Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N417856217001followed by a unit qualifier and the quantityPackage 17856-2170-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Herpes Zoster Infections Acyclovir is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes Acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox Acyclovir is indicated for the treatment of chickenpox (varicella).
Excerpt only. Read the full label for complete information.
About NDC 17856-2170
- What is NDC 17856-2170?
- 17856-2170 is the product NDC for Acyclovir suspension (acyclovir), Acyclovir 200 mg/5mL suspension, listed with the FDA by Atlantic Biologicals Corp.. It has 2 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Acyclovir suspension (Acyclovir).
- What is the active ingredient?
- Acyclovir.
- Who is the labeler?
- Atlantic Biologicals Corp., NDC labeler code 17856. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Acyclovir suspension?
- 1 other product NDC are listed under this name. See all Acyclovir suspension NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Acyclovir suspension products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Acyclovir suspensionacyclovir | Acyclovir 200 mg/5mL | SuspensionOral | Novadoz Pharmaceuticals LLC | 72205-170 | 72205-0170-72 |
Other NDCs under ANDA 217393
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Acyclovir suspensionacyclovir | Acyclovir 200 mg/5mL | SuspensionOral | Novadoz Pharmaceuticals LLC | 72205-170 |